Page last updated: 2024-11-07

metaraminol and Postoperative Nausea and Vomiting

metaraminol has been researched along with Postoperative Nausea and Vomiting in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Postoperative Nausea and Vomiting: Emesis and queasiness occurring after anesthesia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonnell, NJ1
Paech, MJ1
Muchatuta, NA1
Hillyard, S1
Nathan, EA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia[NCT04401345]Phase 4258 participants (Actual)Interventional2020-06-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for metaraminol and Postoperative Nausea and Vomiting

ArticleYear
A randomised double-blind trial of phenylephrine and metaraminol infusions for prevention of hypotension during spinal and combined spinal-epidural anaesthesia for elective caesarean section.
    Anaesthesia, 2017, Volume: 72, Issue:5

    Topics: Acid-Base Equilibrium; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Ces

2017